公司资料
Catalyst Biosciences 股价、新闻与催化剂
- 股票代码:
- CBIO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
13.14 USD (-0.23%)
收盘价
最后更新: 2026年10月22日
469M USD
市值
股价为何变动
截至 2026年10月22日，CBIO 股价变化不大，收于 $13.14。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Catalyst Biosciences was a biotechnology company focused on engineered proteins for hemostasis, complement, and related inflammatory biology before becoming a historical ticker. Its story was built around protein-engineering approaches to difficult disease pathways.
所在地与行业分类
Catalyst Biosciences was headquartered in the United States and listed on NASDAQ. It sat in specialty biotech with a protein-engineering focus.
商业模式特征
The company depended on translational data, strategic direction, and financing while working through a narrow pipeline. Investors historically watched whether the platform could create durable value across multiple programs.
生物医药行业定位
Catalyst Biosciences belongs to the historical engineered-protein biotech bucket. Its stock was highly sensitive to strategic changes and the viability of its platform thesis.
未来催化剂
- Catalyst Biosciences is largely a legacy / closeout story, with catalysts limited to any remaining strategic update. There is no active standalone growth story left.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。